ALGN

Align Technology Inc.

Price

$162.55

return (12m)

8.68%

p/e

28.99

p/bv

2.83

DIVIDEND YIELD

0.00%

ALGN price

Align Technology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.98%

3 months

-0.65%

1 year

8.68%

2 years

-30.53%

5 years

-77.20%

10 years

75.41%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ALGN

Valuation

P/E

28.99

Sector -0.74

Industry 5.42

P/BV

2.83

Sector 1.97

Industry 3.88

P/Revenue (PSR)

2.90

Sector 1.74

Industry 3.79

EV/EBITDA

56.49

Sector -8.33

Industry 25.54

EV/EBIT

56.49

Sector -14.02

Industry -11.16

P/EBITDA

14.80

Sector -44.73

Industry 9.99

P/EBIT

18.38

Sector -45.73

Industry -8.23

P/Total Assets

1.87

Sector 0.91

Industry 1.49

P/Net Current Assets

25.09

Sector -25.37

Industry -4.37

P/Working Capital

15.89

Sector -5.79

Industry 5.81

EPS

5.82

Sector -0.83

Industry -0.21

BVPS

59.61

Sector 3.91

Industry 6.45

Efficiency

Gross Margin

68.05%

Sector 45.33%

Industry 54.34%

EBITDA Margin

18.25%

Sector -312.56%

Industry -12.07%

EBIT Margin

18.25%

Sector -198.10%

Industry -24.61%

Operating Margin

15.76%

Sector -23.11%

Industry -3.00%

Net Profit Margins

9.99%

Sector -28.02%

Industry -7.67%

Asset Turnover

0.16

Sector 0.13

Industry 0.12

Profitability

ROE

9.77%

Sector -29.59%

Industry -24.14%

ROA

6.44%

Sector -28.62%

Industry -6.01%

ROIC

11.42%

Sector -521.05%

Industry -16.46%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.40

Sector 1.85

Industry 2.52

Net Debt / EBITDA

-5.72

Sector -1.07

Industry 10.38

Net Debt / EBIT

-5.72

Sector -1.09

Industry 6.00

Net Debt / Equity

-0.26

Sector -0.34

Industry 0.01

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.55

Equity/Assets

0.66

Sector 0.43

Industry 0.46

Liabilities/Assets

0.34

Sector 0.48

Industry 0.53

Growth

5Y Revenue CAGR

0.93%

Sector -

Industry -

5Y Earnings CAGR

-11.74%

Sector -

Industry -

FAIR VALUE OF Align Technology ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$162.55

Fair Value

$88.35

Upside Return potential.

-45.65%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ALGN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ALGN Align Technology Inc.	$162.55	8.68%	0.00%	28.99	2.83	9.77%	9.99%
ISRG Intuitive Surgical Inc.	$378.81	-20.44%	0.00%	42.99	7.38	17.15%	28.45%
ABT Abbott Laboratories	$116.64	-10.02%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$93.35	4.76%	3.08%	24.65	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$50.37	-52.56%	0.00%	18.39	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$94.77	-20.93%	0.00%	21.76	6.37	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.93	-13.73%	0.00%	38.42	27.15	70.67%	25.03%
RMD ResMed Inc.	$231.52	-20.18%	1.03%	22.16	5.13	23.13%	26.94%
COHR Coherent Inc.	$289.52	222.05%	0.00%	69.45	4.98	7.16%	11.31%
PHG Koninklijke Philips NV	$27.42	0.56%	3.68%	20.32	1.99	9.80%	6.30%
SYK Stryker Corp.	$329.45	-15.36%	1.05%	34.02	5.29	15.55%	14.43%
INMD InMode Ltd.	$15.06	1.69%	0.00%	11.48	1.41	12.32%	20.69%
DXCM DexCom Inc.	$92.34	12.25%	0.00%	34.96	13.33	38.14%	20.12%
EW Edwards Lifesciences Corp.	$89.79	9.73%	0.00%	51.52	4.83	9.37%	15.43%
BDX Becton Dickinson and Company	$192.00	-0.92%	2.21%	55.53	2.14	3.85%	4.05%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.85	22.59%	1.43%	49.03	11.11	22.66%	26.71%
SNN Smith & Nephew PLC	$29.26	-19.31%	2.66%	10.95	2.38	21.74%	9.20%
ZBH Zimmer Biomet Holdings Inc.	$100.98	-5.25%	0.96%	23.88	1.53	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALGN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Align Technology

Align Technology Inc.

Average Investor10 user rating

4.0 (8 people)

United States

29 years

Founded: 1997

2001

Time since IPO - 25 years

18.070

Employees

Align Technology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $11.99 billion, with shareholders equity totaling $4.23 billion.

The company employs approximately 18.070 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Align Technology Inc. reported $4.14 billion in revenue, generating net income of $413.57 million.

Key financial metrics include a P/E ratio of 28.99, a price-to-book (P/B) ratio of 2.83, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALGN.

Market cap

$11.99 billion

Net worth

$4.23 billion

$4,232,450,000.00

Assets

$6.42 billion

$6,417,580,000.00

Total Shares Outstanding

71.00 million

71,000,000

Average Daily Trading Volume

$1.06 million

$1,060,951.70

Sector

Health

Industry

Medical Supplies and Equipment

ALGN

ALGN revenue and profits

Financial Results ALGN

DRAG THE FRAME TO SEE MORE DATA

ALGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.02 34,58% (12M)

P/E

24.36

2.86%

ROE

6.12%

P/BV

1.49

CI - Cigna

$277.51 --6,29% (12M)

P/E

10.67

2.22%

ROE

16.04%

P/BV

1.71

CNC - Centene

$65.02 121,08% (12M)

P/E

-6.26

0.00%

ROE

-22.51%

P/BV

1.41

HUM - Humana

$378.88 28,33% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$45.85 --7,19% (12M)

P/E

7.49

3.84%

ROE

18.43%

P/BV

1.38

LLY - Eli Lilly

$1,255.40 82,09% (12M)

P/E

42.15

0.51%

ROE

78.84%

P/BV

33.23

HCA - HCA Healthcare

$429.19 6,68% (12M)

P/E

13.87

0.70%

ROE

-213.15%

P/BV

-29.56

NVS - Novartis

$158.86 27,54% (12M)

P/E

23.74

1.95%

ROE

30.41%

P/BV

7.22